Peking Union Medical College

This study is observing how well a combination of the immunotherapy drug sugemalimab and standard chemotherapy works for people with advanced non-small cell lung cancer (NSCLC) in real-world medical settings. It aims to see how long the treatment keeps the cancer from getting wor…

This study is testing whether personalized, targeted drug treatments work better than standard chemotherapy for salivary gland cancer. Doctors will test patients' tumors for specific markers and assign them to different drug groups based on the results. The main goal is to see if…

This study aims to measure how common malnutrition risk is in hospitalized patients across China, Europe, and the USA. It will also check if providing extra nutritional support to at-risk patients helps them recover better and is worth the cost. Researchers will survey 2000 patie…